349 related articles for article (PubMed ID: 11650833)
1. The expert surrogate system: a role for the Golden Rule in clinical practice.
Mackillop WJ
Humane Med; 1988 Nov; 4(2):89-95. PubMed ID: 11650833
[No Abstract] [Full Text] [Related]
2. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
3. Proposed guidelines for the participation of persons with dementia as research subjects.
Keyserlingk EW; Glass K; Kogan S; Gauthier S
Perspect Biol Med; 1995; 38(2):319-61. PubMed ID: 11644666
[No Abstract] [Full Text] [Related]
4. Hyperbaric research at Duke University--ethical considerations.
Bennett PB; Kylstra JA
Forsvarsmedicin; 1973; 9(3):373-8. PubMed ID: 11661280
[No Abstract] [Full Text] [Related]
5. Dilemmas in paying for clinical research: the view from the IRB.
Lind SE
IRB; 1987; 9(2):1-5. PubMed ID: 11649900
[No Abstract] [Full Text] [Related]
6. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper.
High DM; Whitehouse PJ; Post SG; Berg L
Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):66-74. PubMed ID: 11657676
[No Abstract] [Full Text] [Related]
7. Proposed revision of the Declaration of Helsinki.
World Medical Association
Bull Med Ethics; 1999 Apr; No. 147():18-22. PubMed ID: 11657218
[No Abstract] [Full Text] [Related]
8. Ethics of clinical trials for research ethics boards: proceedings of a national workshop.
National Council on Bioethics in Human Research (Canada)
NCBHR Commun; 1991; 2(2):4-23. PubMed ID: 11659919
[No Abstract] [Full Text] [Related]
9. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
Kobasic DM
J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
[No Abstract] [Full Text] [Related]
10. NZ medicine after Cartwright.
Gillett G
BMJ; 1990 Apr; 300(6729):892-4. PubMed ID: 11642768
[No Abstract] [Full Text] [Related]
11. Ethics of research involving children.
Lynch A
Ann R Coll Physicians Surg Can; 1992 Oct; 25(6):371-2. PubMed ID: 11659510
[No Abstract] [Full Text] [Related]
12. Perspectives of protocol reviewers.
Moline ML; Aisen MW
J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
[No Abstract] [Full Text] [Related]
13. The ethics of phase I pediatric oncology trials.
Ackerman TF
IRB; 1995; 17(1):1-5. PubMed ID: 11653060
[No Abstract] [Full Text] [Related]
14. Can children be enrolled in a placebo-controlled randomized clinical trial of synthetic growth hormone?
Prentice ED; Antonson DL; Jameton A; Graber B; Sears T
IRB; 1989; 11(1):6-10. PubMed ID: 11659085
[No Abstract] [Full Text] [Related]
15. Ethical aspects of pharmaceutically-based clinical investigation: report on a national workshop.
Miller J; Kinsella D; Klein A; Rusted I
NCBHR Commun; 1990; 1(1):7-10. PubMed ID: 11660185
[No Abstract] [Full Text] [Related]
16. Minimal risk, administrative firm trials, and informed consent.
O'Neil TJ; Goldberg H; McGough H
IRB; 1992; 14(3):9-10, 12. PubMed ID: 11656139
[No Abstract] [Full Text] [Related]
17. Testing the implementation of clinical guidelines.
Goldberg HI; McGough H
IRB; 1991; 13(6):1-7. PubMed ID: 11656109
[No Abstract] [Full Text] [Related]
18. A protocol review guide to reduce IRB inconsistency.
Prentice ED; Antonson DL
IRB; 1987; 9(1):9-11. PubMed ID: 11649892
[No Abstract] [Full Text] [Related]
19. Judging the ethical merit of clinical trials: what criteria do research ethics board members use?
Meslin EM; Lavery JV; Sutherland HJ; Till JE
IRB; 1994; 16(4):6-10. PubMed ID: 11654136
[No Abstract] [Full Text] [Related]
20. The doctor's unproven belief and the subject's informed choice: another commentary.
Marquis D; Stephens R; Levine RJ
IRB; 1989; 11(3):8-11. PubMed ID: 11650208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
